Last Updated: September 24, 2026

Details for New Drug Application (NDA): 218133

✉ Email this page to a colleague

« Back to Dashboard

NDA 218133 describes CALCIUM CHLORIDE 10%, which is a drug marketed by Am Regent, Amneal, Extrovis, Intl Medication Sys, Medefil Inc, Somerset, Square Pharms Plc, and Hospira, and is included in eight NDAs. It is available from fourteen suppliers. Additional details are available on the CALCIUM CHLORIDE 10% profile page.

The generic ingredient in CALCIUM CHLORIDE 10% is calcium chloride. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the calcium chloride profile page.

Summary for 218133

Tradename:	CALCIUM CHLORIDE 10%
Applicant:	Somerset
Ingredient:	calcium chloride
Patents:	0

Pharmacology for NDA: 218133

Mechanism of Action	Phosphate Chelating Activity
Physiological Effect	Increased Coagulation Factor Activity

Suppliers and Packaging for NDA: 218133

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CALCIUM CHLORIDE 10%	calcium chloride	INJECTABLE;INJECTION	218133	ANDA	Somerset Therapeutics, LLC	70069-773	70069-773-10	10 VIAL, GLASS in 1 CARTON (70069-773-10) / 10 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	100MG/ML
Approval Date:	Dec 17, 2024	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.